GlassScriptPhysician profile
Cara M Hamilton
NPI 1578768982
$662.51
in general payments reported to CMS, 2019-2025
13 companies · $197 in 2025
The $197 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $18.92 · 2021: $27.75 · 2022: $66.26 · 2023: $167 · 2024: $185 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $549.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $251.33 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $113.84 | 2020-2025 | Gardasil 9, Vaxelis, Gardasil |
| Collegium Pharmaceutical, INC. | $49.07 | 2025 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $46.40 | 2023-2024 | Qelbree, Qelbree |
| Glaxosmithkline, LLC. | $35.80 | 2021-2025 | Rotarix, Menveo, Bexsero |
| Sanofi Pasteur INC. | $27.53 | 2021-2024 | |
| Sanofi-Aventis U.S. LLC | $23.87 | 2024 | |
| Biomarin Pharmaceutical INC. | $21.19 | 2024 | Voxzogo 1.2mg |
| Seqirus USA INC | $21.09 | 2025 | Flucelvax |
| Baxter Healthcare | $19.11 | 2022 | |
| Kyowa Kirin, INC. | $18.27 | 2023 | Crysvita |
| Ultragenyx Pharmaceutical INC. | $17.68 | 2022 | |
| Daiichi Sankyo INC. | $17.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cara Hamilton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.